233 related articles for article (PubMed ID: 33445954)
21. The impact of genetic variation on sensitivity to opioid analgesics in patients with postoperative pain: a systematic review and meta-analysis.
Ren ZY; Xu XQ; Bao YP; He J; Shi L; Deng JH; Gao XJ; Tang HL; Wang YM; Lu L
Pain Physician; 2015; 18(2):131-52. PubMed ID: 25794200
[TBL] [Abstract][Full Text] [Related]
22. Pain polymorphisms and opioids: An evidence based review.
Vieira CMP; Fragoso RM; Pereira D; Medeiros R
Mol Med Rep; 2019 Mar; 19(3):1423-1434. PubMed ID: 30592275
[TBL] [Abstract][Full Text] [Related]
23. Pharmacogenomics for personalized pain medicine.
Ko TM; Wong CS; Wu JY; Chen YT
Acta Anaesthesiol Taiwan; 2016 Mar; 54(1):24-30. PubMed ID: 26976339
[TBL] [Abstract][Full Text] [Related]
24. Pharmacogenomics in chronic pain therapy: from disease to treatment and challenges for clinical practice.
Yamamoto PA; Conchon Costa AC; Lauretti GR; de Moraes NV
Pharmacogenomics; 2019 Aug; 20(13):971-982. PubMed ID: 31486733
[TBL] [Abstract][Full Text] [Related]
25. Pharmacogenetics-guided analgesics in major abdominal surgery: Further benefits within an enhanced recovery protocol.
Senagore AJ; Champagne BJ; Dosokey E; Brady J; Steele SR; Reynolds HL; Stein SL; Delaney CP
Am J Surg; 2017 Mar; 213(3):467-472. PubMed ID: 27955884
[TBL] [Abstract][Full Text] [Related]
26. Genetic Contribution in Low Back Pain: A Prospective Genetic Association Study.
Margarit C; Roca R; Inda MD; Muriel J; Ballester P; Moreu R; Conte AL; Nuñez A; Morales D; Peiró AM
Pain Pract; 2019 Nov; 19(8):836-847. PubMed ID: 31269327
[TBL] [Abstract][Full Text] [Related]
27. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA
Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421
[TBL] [Abstract][Full Text] [Related]
28. Use of pharmacogenetic data to guide individualized opioid prescribing after surgery.
Rocco R; Thiels CA; Ubl DS; Moyer AM; Habermann EB; Cassivi SD
Surgery; 2019 Oct; 166(4):476-482. PubMed ID: 31320226
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetics of OPRM1.
Crist RC; Berrettini WH
Pharmacol Biochem Behav; 2014 Aug; 123():25-33. PubMed ID: 24201053
[TBL] [Abstract][Full Text] [Related]
30. The Role of Pharmacogenomics in Postoperative Pain Management.
Sachtleben EP; Rooney K; Haddad H; Lassiegne VL; Boudreaux M; Cornett EM; Kaye AD
Methods Mol Biol; 2022; 2547():505-526. PubMed ID: 36068475
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenomics of oxycodone: a narrative literature review.
Umukoro NN; Aruldhas BW; Rossos R; Pawale D; Renschler JS; Sadhasivam S
Pharmacogenomics; 2021 Apr; 22(5):275-290. PubMed ID: 33728947
[TBL] [Abstract][Full Text] [Related]
32. Pharmacogenomics of Opioid Treatment for Pain Management.
Howes S; Cloutet AR; Kweon J; Powell TL; Raza D; Cornett EM; Kaye AD
Methods Mol Biol; 2022; 2547():491-504. PubMed ID: 36068474
[TBL] [Abstract][Full Text] [Related]
33. Clinical application of pharmacogenetics in pain management.
Smith DM; Weitzel KW; Cavallari LH; Elsey AR; Schmidt SO
Per Med; 2018 Mar; 15(2):117-126. PubMed ID: 29714124
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment.
Walter C; Lötsch J
Pain; 2009 Dec; 146(3):270-275. PubMed ID: 19683391
[TBL] [Abstract][Full Text] [Related]
35. Design and rational for the precision medicine guided treatment for cancer pain pragmatic clinical trial.
Mosley SA; Hicks JK; Portman DG; Donovan KA; Gopalan P; Schmit J; Starr J; Silver N; Gong Y; Langaee T; Clare-Salzler M; Starostik P; Chang YD; Rajasekhara S; Smith JE; Soares HP; George TJ; McLeod HL; Cavallari LH
Contemp Clin Trials; 2018 May; 68():7-13. PubMed ID: 29535047
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients.
Muriel J; Margarit C; Barrachina J; Ballester P; Flor A; Morales D; Horga JF; Fernández E; Peiró AM
Basic Clin Pharmacol Toxicol; 2019 Apr; 124(4):439-448. PubMed ID: 30549211
[TBL] [Abstract][Full Text] [Related]
37. Influence of Cytochrome P450, Family 2, Subfamily D, Polypeptide 6 (CYP2D6) polymorphisms on pain sensitivity and clinical response to weak opioid analgesics.
Zahari Z; Ismail R
Drug Metab Pharmacokinet; 2014; 29(1):29-43. PubMed ID: 23759977
[TBL] [Abstract][Full Text] [Related]
38. Clinical implications of opioid pharmacogenetics.
Argoff CE
Clin J Pain; 2010 Jan; 26 Suppl 10():S16-20. PubMed ID: 20026961
[TBL] [Abstract][Full Text] [Related]
39. An Expert Review of Pharmacogenomics of Sickle Cell Disease Therapeutics: Not Yet Ready for Global Precision Medicine.
Mnika K; Pule GD; Dandara C; Wonkam A
OMICS; 2016 Oct; 20(10):565-574. PubMed ID: 27636225
[TBL] [Abstract][Full Text] [Related]
40. OCT1 pharmacogenetics in pain management: is a clinical application within reach?
Tzvetkov MV
Pharmacogenomics; 2017 Nov; 18(16):1515-1523. PubMed ID: 29061087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]